|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 25 studies with search of: | Hereditary Neuropathies |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy
|
||||
| 2 | Recruiting |
A Randomized, Double-Blind, Placebo-Controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON)
|
||||
| 3 | Completed |
Ascorbic Acid Treatment in CMT1A Trial (AATIC)
|
||||
| 4 | Enrolling by invitation |
Transcorneal Electrical Stimulation Therapy for Retinal Disease
|
||||
| 5 | Recruiting |
Study of Inherited Neurological Disorders
|
||||
| 6 | Completed |
Phenotype/Genotype Correlations in Neuromuscular Disorders
|
||||
| 7 | Recruiting |
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
|
||||
| 8 | Completed |
Safety Study of Idebenone to Treat Friedreich's Ataxia
|
||||
| 9 | Active, not recruiting |
Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis
|
||||
| 10 | Completed |
Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
|
||||
| 11 | Completed |
Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia
|
||||
| 12 | Completed |
Follow up and Observation of Charcot Marie Tooth Disease in Families
|
||||
| 13 | Completed |
Nerve Entrapment in Diabetic Patients
|
||||
| 14 | Recruiting |
Open-Label Safety and Efficacy Evaluation of Fx-1006A in Patients With Transthyretin Amyloidosis
|
||||
| 15 | Active, not recruiting |
An Open-Label Extension of Study Fx-005 Evaluating Long-Term Safety and Clinical Outcomes of Fx-1006A in Patients With Transthyretin Amyloid Transthyretin Amyloidosis With Polyneuropathy
|
||||
| 16 | Active, not recruiting |
High Dose Ascorbic Acid Treatment of CMT1A
|
||||
| 17 | Completed |
Pain and Sensory Changes Assessment in HIV+ Patients
|
||||
| 18 | Completed |
An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease
|
||||
| 19 | Completed |
An Open-Label Maintenance Study of the Enzyme Replacement Therapy Replagal in Patients With Fabry Disease
|
||||
| 20 | Completed |
Role of Polymorphisms in the IL-1 Gene Cluster
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-25) |
|